Jun 27 |
Expanded Access to XHANCE with Addition to National Commercial Formularies
|
Jun 1 |
When Will OptiNose, Inc. (NASDAQ:OPTN) Breakeven?
|
May 18 |
OptiNose, Inc. (OPTN) Q1 2024 Earnings Call Transcript
|
May 17 |
Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
|
May 15 |
Q1 2024 OptiNose Inc Earnings Call
|
May 15 |
OptiNose Inc (OPTN) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Financial ...
|
May 14 |
OptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates
|
May 14 |
Optinose GAAP EPS of -$0.12, revenue of $14.88M
|
May 14 |
Optinose Reports First Quarter 2024 Financial ResultsĀ and Recent Operational Highlights
|
May 10 |
OptiNose Inc (OPTN) Announces $55 Million Financing Round Amidst Revenue Projections
|